Global Cord Blood (NYSE:CO) Research Coverage Started at StockNews.com

StockNews.com assumed coverage on shares of Global Cord Blood (NYSE:CO) in a research report released on Thursday morning. The firm issued a strong-buy rating on the medical research company’s stock.

Global Cord Blood Trading Up 4.0 %

Shares of NYSE CO opened at $1.30 on Thursday. The firm has a market capitalization of $158.02 million, a price-to-earnings ratio of 2.03 and a beta of 0.16. Global Cord Blood has a one year low of $2.03 and a one year high of $5.50. The business has a fifty day simple moving average of $1.55 and a 200 day simple moving average of $1.40.

About Global Cord Blood

Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage service. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The firm preserves cord blood units donated by the public and provides matching services on such donated units and deliver matching units to patients in need of transplants.